Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

3(75.0%)

Phase 3

1(25.0%)

4Total

N/A(3)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT07288593Not ApplicableNot Yet Recruiting

INSIGHT: Insomnia, Nightmares, and Sympathetic Hyperactivity Intervention

Role: collaborator

NCT05547880Completed

CNS Correlates of Extended Sleep Restriction

Role: collaborator

NCT05623046Not ApplicableCompleted

Building Emotional Self-Awareness Teletherapy (BEST)

Role: collaborator

NCT04776304Not ApplicableCompleted

Art Therapy QEEG Study for Service Members with a Traumatic Brain Injury and Posttraumatic Stress Symptoms

Role: collaborator

NCT01352637Phase 3Completed

Enhancing Exposure Therapy for Post Traumatic Stress Disorder (PTSD): Virtual Reality and Imaginal Exposure With a Cognitive Enhancer

Role: collaborator

All 5 trials loaded